Chemistry Ventures Raises $500M for Second Fund Backed by Top-tier VC Alumni

Chemistry Ventures, a venture capital firm launched by alumni from Bessemer Venture Partners, Index Ventures, and Andreessen Horowitz, is currently raising $500 million for its second fund. This sizable fundraise underscores continued limited partner enthusiasm for teams with proven track records, even as the broader venture market navigates a cautious environment.

The $500 million target represents a significant step-up from Chemistry’s debut fund, signaling both the founders’ ability to attract capital and the strength of their investment thesis focused on early-stage startups. The firm’s pedigree, combining expertise from three of Silicon Valley’s top VC firms, positions it to leverage extensive networks and domain knowledge across sectors.

For founders, Chemistry’s growing war chest means access to a well-connected investor with a deep understanding of scaling startups and navigating market cycles. For investors, the fundraise highlights a preference for experienced teams who can deploy capital judiciously amid ongoing macroeconomic uncertainty.

Looking ahead, Chemistry Ventures’ successful raise could encourage other VC firms led by established partners to launch follow-on funds, reinforcing a bifurcated market where seasoned investors continue to attract capital while newer entrants face more challenges. Market watchers should monitor Chemistry’s deployment pace and portfolio construction as indicators of early-stage investment trends in 2026.